Is CRXT or DGRO a better dividend investment in 2026?

CRXT currently yields 4210.53% with a 5% 5-year dividend growth rate. DGRO yields 2.10% with 9.5% growth. The better choice depends on your goal: CRXT offers higher current income.

What is the dividend yield difference between CRXT and DGRO?

CRXT has a forward dividend yield of 4210.53% ($2.00/share annually). DGRO yields 2.10% ($1.47/share annually). The yield gap is 4208.43 percentage points.

Home › Compare › CRXT vs DGRO

CRXT vs DGRO: Dividend Comparison 2026

CRXT yields 4210.53% · DGRO yields 2.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRXT wins by $11772529661935.05M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRXT

● Live price

4210.53%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$11772529661935.08M

Annual income

$11,247,068,373,781,045,000.00

Full CRXT calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.10%

Share price

$70.18

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$235.38

Full DGRO calculator →

Portfolio growth — CRXT vs DGRO

📍 CRXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRXT	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRXT + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRXT pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRXT

Annual income on $10K today (after 15% tax)

$357,894.74/yr

After 10yr DRIP, annual income (after tax)

$9,560,008,117,713,887,000.00/yr

DGRO

Annual income on $10K today (after 15% tax)

$178.14/yr

After 10yr DRIP, annual income (after tax)

$200.07/yr

At 15% tax rate, CRXT beats the other by $9,560,008,117,713,887,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRXT + DGRO for your $10,000?

CRXT: 50%DGRO: 50%

100% DGRO50/50100% CRXT

Portfolio after 10yr

$5886264830967.55M

Annual income

$5,623,534,186,890,523,000.00/yr

Blended yield

95.54%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CRXT right now

CRXT

Analyst Ratings

Buy

Hold

Consensus: Buy

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRXT buys

DGRO buys

No recent congressional trades found for CRXT or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRXTDGRO

Forward yield	4210.53% ✓	2.10%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$11772529661935.08M ✓	$31.6K
Annual income after 10y	$11,247,068,373,781,045,000.00 ✓	$235.38
Total dividends collected	$11736758602549.12M ✓	$2.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CRXT vs DGRO ($10,000, DRIP)

Year	CRXT Portfolio	CRXT Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$431,753	$421,052.63	$11,290	$209.57	+$420.5K → CRXT
2	$17,451,749	$16,989,773.99	$12,722	$213.54	+$17.44M → CRXT
3	$660,485,318	$641,811,946.18	$14,314	$217.18	+$660.47M → CRXT
4	$23,407,888,248	$22,701,168,957.98	$16,080	$220.53	+$23407.87M → CRXT
5	$776,952,371,738	$751,905,931,312.87	$18,040	$223.59	+$776952.35M → CRXT
6	$24,155,814,960,562	$23,324,475,922,802.33	$20,215	$226.40	+$24155814.94M → CRXT
7	$703,574,699,225,543	$677,727,977,217,741.50	$22,627	$228.96	+$703574699.20M → CRXT
8	$19,201,286,500,349,684	$18,448,461,572,178,350.00	$25,302	$231.31	+$19201286500.32M → CRXT
9	$491,085,316,031,806,900	$470,539,939,476,432,700.00	$28,268	$233.44	+$491085316031.78M → CRXT
10	$11,772,529,661,935,080,000	$11,247,068,373,781,045,000.00	$31,557	$235.38	+$11772529661935.05M → CRXT

CRXT vs DGRO: Complete Analysis 2026

CRXT — Stock

Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

Full CRXT Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this CRXT vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRXT vs SCHD CRXT vs JEPI CRXT vs O CRXT vs KO CRXT vs MAIN CRXT vs VIG CRXT vs NOBL CRXT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.